Apollo Ingredients Ltd
₹ 6.58
4.94%
19 Nov
- close price
About
Incorporated in 1980, Apollo Ingredients Ltd is
in the business of providing healthcare solutions[1]
Key Points
- Market Cap ₹ 6.84 Cr.
- Current Price ₹ 6.58
- High / Low ₹ 6.58 / 5.43
- Stock P/E 32.6
- Book Value ₹ 5.95
- Dividend Yield 0.00 %
- ROCE 10.6 %
- ROE 8.13 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Stock is trading at 1.11 times its book value
- Promoter holding has increased by 4.78% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -6.69% over past five years.
- Company has a low return on equity of 2.55% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.55 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 4.34 | 4.58 | 2.37 | 0.00 | 1.00 | 3.07 | 2.91 | |
| 5.48 | 0.51 | 0.17 | 0.17 | 0.17 | 0.17 | 4.26 | 4.45 | 2.41 | 0.10 | 0.92 | 2.95 | 2.70 | |
| Operating Profit | 0.07 | -0.11 | -0.17 | -0.17 | -0.17 | -0.17 | 0.08 | 0.13 | -0.04 | -0.10 | 0.08 | 0.12 | 0.21 |
| OPM % | 1.26% | -27.50% | 1.84% | 2.84% | -1.69% | 8.00% | 3.91% | 7.22% | |||||
| 0.24 | 0.19 | 0.12 | 0.12 | 0.11 | 0.10 | 0.11 | 0.14 | 0.12 | 0.03 | 0.00 | 0.01 | 0.00 | |
| Interest | 0.14 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.17 | -0.01 | -0.05 | -0.05 | -0.06 | -0.07 | 0.19 | 0.27 | 0.08 | -0.07 | 0.08 | 0.13 | 0.21 |
| Tax % | 29.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.79% | 22.22% | 25.00% | 0.00% | 25.00% | 23.08% | |
| 0.12 | -0.01 | -0.05 | -0.05 | -0.06 | -0.07 | 0.16 | 0.21 | 0.06 | -0.07 | 0.06 | 0.10 | 0.21 | |
| EPS in Rs | 0.06 | -0.07 | 0.06 | 0.10 | 0.19 | ||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | -7% |
| 3 Years: | 9% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | -9% |
| 3 Years: | 19% |
| TTM: | 520% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 6% |
| 3 Years: | 3% |
| Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 5.20 |
| Reserves | 1.00 | 1.00 | 0.95 | 0.69 | 0.63 | 0.56 | 0.72 | 0.93 | 0.99 | 0.92 | 0.98 | 1.08 | 0.99 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.24 | 0.20 | 0.01 | 0.01 | 0.01 | 0.01 | 0.10 | 0.01 | 0.02 | 0.04 | 0.54 | 0.40 | 0.30 | |
| Total Liabilities | 1.44 | 1.40 | 1.16 | 0.90 | 0.84 | 0.77 | 1.02 | 1.14 | 1.21 | 1.16 | 1.72 | 1.68 | 6.49 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.21 | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 1.23 | 1.19 | 0.95 | 0.90 | 0.84 | 0.77 | 1.02 | 1.14 | 1.21 | 1.16 | 1.72 | 1.68 | 6.49 | |
| Total Assets | 1.44 | 1.40 | 1.16 | 0.90 | 0.84 | 0.77 | 1.02 | 1.14 | 1.21 | 1.16 | 1.72 | 1.68 | 6.49 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | -0.01 | 0.01 | 0.00 | 0.00 | -0.01 | 0.11 | -0.04 | 0.01 | 0.10 | 1.47 | -0.12 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | |
| Net Cash Flow | 0.00 | -0.01 | 0.01 | 0.00 | 0.00 | -0.01 | 0.11 | -0.04 | 0.01 | 0.11 | 1.47 | -0.12 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Working Capital Days | 63.79 | 894.25 | 66.44 | 82.88 | 166.33 | -164.25 | -32.10 | |||||
| ROCE % | 27.07% | 6.67% | -4.26% | -4.90% | -6.98% | -8.81% | 22.62% | 26.34% | 6.90% | -6.06% | 6.96% | 10.57% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - In accordance with regulation 47 of SEBI (LODR) 2015, We enclose herewith the copies of Newspaper Advertisement published of Standalone Unaudited Financial Statements for the …
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Monitoring agency reports Rs5.00 crore rights issue fully subscribed; proceeds unutilized, parked in Axis Bank as of Sept 30, 2025.
- Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2025. 14 Nov
-
Board Meeting Outcome for Outcome Of The Board Meeting- Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015.
14 Nov - Unaudited Q2/H1 results to Sept 30, 2025; Rs.500 lakh rights issue; H1 loss Rs.8.37 lakh.
-
Board Meeting Intimation for Intimation Of The Board Meeting Of The Company
10 Nov - Board meeting on 14 Nov 2025 to consider unaudited results for quarter and half-year ended 30 Sep 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
AIL (formerly Indsoya Ltd) is an integrated healthcare solutions provider focusing on the manufacture, import, and export of Ayurvedic, Homeopathic, and Allopathic medicines. The company is also expanding into setting up and managing hospitals, diagnostic and wellness centres, and pathology labs, while offering value-added services such as clinical audits, hospital consultancy, and healthcare staffing solutions. It aims to leverage opportunities across traditional and modern medical systems both in India and international markets.